Oral antibiotics versus parenteral antibiotics for severe pneumonia in children
1Pontificia Universidad Javeriana, Epidemiology Unit, Faculty of Medicine, Hospital Universitario de San Ignacio, Cr. 7 #40-62, 2nd floor, Bogota, DC, Colombia. mxrojas@gmail.com
Insights
Oral antibiotics are as effective and safe as parenteral antibiotics for treating severe pneumonia in children. This approach reduces pain and complications associated with injections, improving treatment compliance.
Area of Science:
- Pediatrics
- Infectious Diseases
- Pharmacology
Background:
- Acute respiratory infection (ARI) is a major cause of child mortality in developing nations.
- Parenteral antibiotics are standard for suspected bacterial infections but cause pain, compliance issues, and needle-related complications.
- Limited resources for parenteral therapy can necessitate costly and risky child transfers.
Purpose of the Study:
- To compare the effectiveness and safety of oral versus parenteral antibiotic therapies for severe pneumonia in children aged three months to five years.
- To evaluate oral antibiotic therapy as a viable alternative to parenteral administration in pediatric severe pneumonia cases.
Main Methods:
- Systematic review of randomized controlled trials (RCTs) and quasi-RCTs.
- Searched major databases including CENTRAL, MEDLINE, EMBASE, and LILACS.
- Included studies compared oral antibiotic therapy with parenteral antibiotic therapy for severe pneumonia in children.
Main Results:
- Two trials involving 134 and 1702 children were analyzed.
- Oral co-trimoxazole showed similar treatment failure rates to intramuscular procaine penicillin/oral ampicillin (9.1% vs 10.2%).
- Oral amoxicillin demonstrated equivalent effectiveness to intravenous penicillin followed by oral amoxicillin (19% vs 19% treatment failure).
Conclusions:
- Oral antibiotic therapy is a safe and effective alternative to parenteral antibiotics for hospitalized children with severe pneumonia.
- This approach is particularly beneficial for children without severe symptoms, avoiding the drawbacks of injections.
- Findings support the use of oral antibiotics to improve patient comfort and reduce healthcare burdens.
Background:
Acute respiratory infection (ARI) is one of the leading causes of morbidity and mortality in children under five years of age in developing countries. When hospitalisation is required, the usual practice includes administering parenteral antibiotics if a bacterial infection is suspected. This has disadvantages as it causes pain and discomfort to the children, which may lead to treatment refusal or reduced compliance. It is also associated with needle-related complications. In some settings this equipment is in short supply or unavailable necessitating transfer of the child, which increases risks and healthcare costs.
Objectives:
To determine the equivalence in effectiveness and safety of oral antibiotic compared to parenteral antibiotic therapies in the treatment of severe pneumonia in children between three months and five years of age.
Search Strategy:
We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library Issue 2, 2005); MEDLINE (January 1966 to July 2005); EMBASE (January 1990 to July 2005) and LILACS (February 2005).
Selection Criteria:
The review included published or unpublished randomised controlled trials (RCTs) and quasi-RCTs comparing any oral antibiotic therapy with any parenteral antibiotic therapy for the treatment of severe pneumonia in children from three months to five years of age.
Data Collection And Analysis:
The search yielded more than 1300 titles. Only three studies met all criteria for eligibility. One of the identified trials is yet to publish its results. We did not perform a meta-analysis because of clinical heterogeneity of therapies compared in the included trials.
Main Results:
Campbell 1988 compared oral co-trimoxazole versus intramuscular procaine penicillin followed by oral ampicillin in 134 children. At the seventh day of follow up, treatment failure occurred in 6/66 (9.1%) in the oral co-trimoxazole group and 7/68 (10.2%) in the combined-treatment group. The risk difference was -0.01% (95% confidence interval (CI) -0.11 to 0.09). The APPIS Group 2004 evaluated 1702 patients comparing oral amoxicillin versus intravenous penicillin for two days followed by oral amoxicillin. After 48 hours, treatment failure occurred in 161/845 (19%) in the amoxicillin group and 167/857 (19%) in the parenteral penicillin group. The risk difference was -0.4% (95% CI -4.2 to 3.3). The authors reported similar recovery in both groups at 5 and 14 days.
Authors' Conclusions:
Oral therapy appears to be an effective and safe alternative to parenteral antibiotics in hospitalised children with severe pneumonia who do not have any serious signs or symptoms.
Related Concept Videos
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:14Atypical Pneumonia
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
01:30Pneumonia III: Complications and Assessment
01:29Pneumonia I: Introduction
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...